ArticleKidney international reports2025

Prospective Pilot Study of Plasma Cell-Targeted Therapy With Bortezomib in Refractory IgA Nephropathy.

Li Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.